Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough



Rating:

Share or cite this content

Citations should be made in the following way:
S. Couillard (Oxford, United Kingdom), R. Shrimanker (Oxford, United Kingdom), G. Hynes (Oxford, United Kingdom), C. Borg (Oxford, United Kingdom), C. Connolly (Oxford, United Kingdom), A. Hayman (Oxford, United Kingdom), S. Thulborn (Oxford, United Kingdom), A. Moran (Oxford, United Kingdom), S. Poole (Oxford, United Kingdom), T. Powell (Oxford, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom), A. Mansur (Birmingham, United Kingdom), L. Mcgarvey (Belfast, United Kingdom), L. Heaney (Oxford, United Kingdom), S. Fowler (Manchester, United Kingdom), P. Bradding (Leicester, United Kingdom), I. Pavord (Oxford, United Kingdom), T. Hinks (Oxford, United Kingdom). Raised FeNO in optimally-treated severe asthma identifies persistent eosinophilic chemotactic pull towards the airway. 3111

Member's Comments

No comment yet.

Related content which might interest you: Spontaneous airway obstruction masks FeNO level in patients with asthma but not COPD Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Bronchial hyper-responsiveness in chronic eosinophilic pneumonia is not correlated uniquely to local eosinophil infiltration Source: Eur Respir J 2002; 20: Suppl. 38, 315s Year: 2002 FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO. Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Mepolizumab improves small airway function in severe eosinophilic asthma Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions Year: 2018 Role of neutrophils in airway inflammation in children with severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Parameters associated with persistent airflow obstruction in chronic severe asthma Source: Eur Respir J 2004; 24: 122-128 Year: 2004 Induced sputum IL-13 concentration in asthma, COPD and eosinophilic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 594s Year: 2004 Induced sputum and airway inflammation in asthma and COPD Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006 Factors driving airway eosinophilia in prednisone-dependent severe asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017 Eosinophilic airway inflammation in COPD and asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Sputum eosinophilia vs exhaled NO as markers of airways inflammation in asthma: relationship with asthma control Source: Eur Respir J 2005; 26: Suppl. 49, 736s Year: 2005 Exhaled markers in the monitoring of airways inflammation in mild persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 679s Year: 2004 eNO, ECP and bronchial hyperresponsiveness in mild asthmatic children out of therapy Source: Eur Respir J 2005; 26: Suppl. 49, 42s Year: 2005 Increasing sputum basophils is a marker for eosinophil-dominant airway inflammation in adult asthma Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Source: Eur Respir J 2001; 18: 444-450 Year: 2001 Galectn-3 : marker of airway inflammation in bronchial asthma Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019